Series A startup

Who invested in ABAC Therapeutics

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$20Mraised across 1 round since 2018, from 1 source

Latest round
Series A, $20MFeb 2018
Investors
1
See who backed them

The rounds

  1. Feb 2018
    Series A$20M

    Source recorded

Everyone who backed them

Missing a round, or an investor who was in one? Tell us.

Quick answers about ABAC Therapeutics

Who invested in ABAC Therapeutics?

ABAC Therapeutics's investors include Criteria Venture Tech.

How much has ABAC Therapeutics raised?

ABAC Therapeutics has raised $20M across 1 round since 2018.

When did ABAC Therapeutics last raise?

ABAC Therapeutics's most recent round was a Series A of $20M in Feb 2018.

What was ABAC Therapeutics's biggest round?

Its most recent round, $20M in Feb 2018, is also its largest on record.

Who backed ABAC Therapeutics first?

ABAC Therapeutics's first round on record, in Feb 2018, was backed by Criteria Venture Tech.

What stage is ABAC Therapeutics at?

ABAC Therapeutics's latest named round is a Series A, in Feb 2018.

Companies like ABAC Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.